Vasade Biosciences

Vasade Biosciences is a private U.S. biotechnology company focused on developing pharmacological inhibitors of adenylyl cyclase type 5 for cardiovascular and age-related diseases. The company appears to have built its program around small-molecule AC5 inhibition for cardioprotection, particularly in myocardial infarction and congestive heart failure, and has also pursued Alzheimer's disease through an NIH-supported STTR project. Publicly available grant and patent records indicate that its work remains preclinical, with lead compounds such as C90 described in animal studies rather than human clinical development. Vasade has been funded in part through U.S. government SBIR/STTR and NIH support and has historical ties to cardiovascular research groups in New Jersey.